Enanta Pharmaceuticals ENTA
NASDAQ ENTA
$12.64 +0.03 (+0.20%)
At close: Sep 29, 2026 · 4:00 PM EDT

Enanta Pharmaceuticals (ENTA) Current Assets (2012 - 2026)

Updated

Enanta Pharmaceuticals' Current Assets was $203.62 million in fiscal Q3 2026 (quarter ended Jun 30, 2026), down 8.6% from $222.71 million a year earlier but up 14.1% from the prior quarter.

Analysis

Enanta Pharmaceuticals (ENTA) Current Assets (2012 - 2026) Analysis & Trends

At the end of FY2025 (ended Sep 30, 2025), Current Assets at Enanta Pharmaceuticals came in at $204.34 million, down 31.9% from FY2024.

  • Current Assets shows a five-year compound annual growth rate of -14.1% (FY2020 to FY2025).
  • In earlier fiscal years, Current Assets was $299.85 million in FY2024 (-29.1%), $422.79 million in FY2023 (+35.6%), $311.71 million in FY2022 (-2.3%) and $319.02 million in FY2021 (-27.0%).
  • Quarterly Current Assets has moved between $178.41 million (fiscal Q2 2026) and $448.47 million (fiscal Q3 2023) over five years.
  • Compared with a year earlier, Current Assets has declined for nine straight quarters, with an average decline of 25.8% over the last eight quarters.
  • The best year-over-year quarter for Current Assets over five years was fiscal Q3 2023 (growth of 43.3%); the worst was fiscal Q3 2024 (a decline of 36.1%).
  • Per Business Quant data, ENTA's Current Assets in the three fiscal quarters before Q3 2026 was $178.41 million (Q2 2026), $198.68 million (Q1 2026) and $204.34 million (Q4 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Current Assets (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn 59.77 Bn
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn 33.67 Bn
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn 36.68 Bn
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn 27.35 Bn
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn 27.97 Bn
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn 34.96 Bn
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn 13.95 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn 41.36 Bn
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn 12.54 Bn
10 Enanta Pharmaceuticals 367.20 Mn -360.79 Mn - 203.62 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 203.62 Mn
Mar 31, 2026 178.41 Mn
Dec 31, 2025 198.68 Mn
Sep 30, 2025 204.34 Mn
Jun 30, 2025 222.71 Mn
Mar 31, 2025 242.86 Mn
Dec 31, 2024 268.15 Mn
Sep 30, 2024 299.85 Mn
Jun 30, 2024 286.58 Mn
Mar 31, 2024 351.03 Mn
Dec 31, 2023 390.30 Mn
Sep 30, 2023 422.79 Mn
Jun 30, 2023 448.47 Mn
Mar 31, 2023 271.14 Mn
Dec 31, 2022 283.70 Mn
Sep 30, 2022 311.71 Mn
Jun 30, 2022 313.04 Mn
Mar 31, 2022 341.87 Mn
Dec 31, 2021 326.96 Mn
Sep 30, 2021 319.02 Mn
API Access

Enanta Pharmaceuticals Current Assets API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=current-assets&ticker=ENTA&period=max&api_key=YOUR_API_KEY